UNP Scores $32M for AI-Powered Macrocycle Therapeutics
HIT Consultant
DECEMBER 19, 2023
What You Should Know: – Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding. – Led by Merck Global Health Innovation Fund (MGHIF) and TechBio-focused ARTIS Ventures , the funding will help propel UNP’s innovative platform and expand its reach beyond oncology, tackling a wider range of medical challenges.
59 59
Let's personalize your content